Epidemiological Study to Identify Prognosis and Predictive Biomarkers for Advanced or Metastatic Renal Cell Carcinoma

NCT03519542 · clinicaltrials.gov ↗

COMPLETED

Status

62

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Renal Cell Carcinoma

Interventions

DRUG: Sunitinib

Sponsor

Spanish Oncology Genito-Urinary Group